IINN Inspira Technologies: Operating Margin

Inspira Technologies Oxy is characterized by a distinct pre-revenue status and the high regulatory risks typical of a single-product biotech company. Historical operating margin helps track the efficiency of core operations, with the metric recorded at -4710.70. Inspira Technologies Oxy develops unique blood oxygenation systems that operate without mechanical ventilation. The business model's revenue is based on the procurement of innovative equipment by public and private clinics.
Inspira Technologies Oxy B.H.N. Ltd. - analytical breakdowns and key metrics (IINN)

Scaling robotic assembly lines for ECMO systems and automating AI-driven telemetry processing at Inspira Technologies Oxy (IINN) require significant capital expenditures, which impact current efficiency. Operating margin measures the share of profit from core operations before accounting for debt load and taxes, allowing investors to assess internal profitability and the resilience of the business model through operating margin indicators.